Target Name: RALA
NCBI ID: G5898
Review Report on RALA Target / Biomarker Content of Review Report on RALA Target / Biomarker
RALA
Other Name(s): HINCONS | RAS-like protein A | OTTHUMP00000158977 | RALA_HUMAN | OTTHUMP00000207663 | MGC48949 | RALA Ras like proto-oncogene A | RAL | ras related GTP binding protein A | Ras-related protein Ral-A | Ras family small GTP binding protein RALA | v-ral simian leukemia viral oncogene homolog A (ras related) | RAS like proto-oncogene A

Understanding The Potential Drug Target RALA

RALA (HINCONS) is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and kidney. It is a member of the heat shock protein (HSP) family and is involved in a variety of cellular processes that are critical for cell survival. While the exact function of RALA is not yet fully understood, research has shown that it plays an important role in the regulation of inflammation, stress responses, and cellular signaling.

Drug Targeting

RALA is a potential drug target due to its unique structure and the various functions that it is involved in. One of the main reasons for its potential as a drug target is its high level of expression in multiple tissues, which makes it an attractive target for small molecules that can inhibit its activity without affecting its presence in other tissues. Additionally, its protein expression is often regulated by various signaling pathways, which can make it more responsive to drugs that target specific signaling pathways.

Antibiotic Resistance

RALA is also a potential drug target for antibiotic resistance. Many bacteria and viruses have developed antibiotic resistance, which can make them difficult to treat. RALA has been shown to be involved in the regulation of bacterial Streptococcus pneumoniae memory activity post-transcriptional nitrogenous (RNA)-binding protein (RAB), which may be one of the reasons for the resistance of Daomonas to many antibiotics. In addition, studies have also shown that RALA is also expressed in certain microorganisms and tumor cells, making it a potential antimicrobial and antitumor drug target.

Stress Response

RALA is also involved in the regulation of cellular stress responses. During times of stress, cells are able to detect and respond to various signaling cues, including the production of reactive oxygen species (ROS) and the activation of various signaling pathways. RALA has been shown to play a role in the regulation of cellular stress responses by activating the heat shock factor (HSF) and the stress-responsive cDNA-binding protein (SRC).

Regulation of Cellular Signaling

RALA is also involved in the regulation of cellular signaling pathways. It has been shown to play a role in the regulation of cell proliferation and differentiation by interacting with various signaling pathways, including the TGF-β pathway. Additionally, RALA has been shown to play a role in the regulation of cell survival by interacting with the p53 pathway.

Conclusion

In conclusion, RALA is a protein that has been shown to be involved in a variety of cellular processes that are critical for cell survival. Its high level of expression in multiple tissues and its involvement in various signaling pathways make it a potential drug target. potential targets for RALA include small molecules that can inhibit its activity without affecting its in other tissues, as well as antibiotics that can target its expression in bacteria and viruses that have developed antibiotic resistance. Further research is needed to fully understand the functions of RALA and its potential as a drug target.

Protein Name: RAS Like Proto-oncogene A

Functions: Multifunctional GTPase involved in a variety of cellular processes including gene expression, cell migration, cell proliferation, oncogenic transformation and membrane trafficking. Accomplishes its multiple functions by interacting with distinct downstream effectors (PubMed:18756269, PubMed:19306925, PubMed:20005108, PubMed:21822277, PubMed:30500825). Acts as a GTP sensor for GTP-dependent exocytosis of dense core vesicles. The RALA-exocyst complex regulates integrin-dependent membrane raft exocytosis and growth signaling (PubMed:20005108). Key regulator of LPAR1 signaling and competes with GRK2 for binding to LPAR1 thus affecting the signaling properties of the receptor. Required for anchorage-independent proliferation of transformed cells (PubMed:19306925). During mitosis, supports the stabilization and elongation of the intracellular bridge between dividing cells. Cooperates with EXOC2 to recruit other components of the exocyst to the early midbody (PubMed:18756269). During mitosis, also controls mitochondrial fission by recruiting to the mitochondrion RALBP1, which mediates the phosphorylation and activation of DNM1L by the mitotic kinase cyclin B-CDK1 (PubMed:21822277)

The "RALA Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RALA comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

RALB | RALBP1 | RALBP1P1 | RalGAP1 complex | RALGAPA1 | RALGAPA2 | RALGAPB | RALGDS | RALGPS1 | RALGPS2 | RALY | RALYL | RAMAC | RAMACL | RAMP1 | RAMP2 | RAMP2-AS1 | RAMP3 | RAN | RANBP1 | RANBP10 | RANBP17 | RANBP1P1 | RANBP2 | RANBP3 | RANBP3-DT | RANBP3L | RANBP6 | RANBP9 | RANGAP1 | RANGRF | RANP1 | RANP6 | RAP1A | RAP1B | RAP1BL | RAP1GAP | RAP1GAP2 | RAP1GDS1 | RAP2A | RAP2B | RAP2C | RAP2C-AS1 | RAPGEF1 | RAPGEF2 | RAPGEF3 | RAPGEF4 | RAPGEF4-AS1 | RAPGEF5 | RAPGEF6 | RAPGEFL1 | RAPH1 | RAPSN | RARA | RARA-AS1 | RARB | RARG | RARRES1 | RARRES2 | RARS1 | RARS2 | Ras GTPase | Ras-Related C3 Botulinum Toxin Substrate (RAC) | Ras-related protein Ral | RASA1 | RASA2 | RASA3 | RASA4 | RASA4B | RASA4CP | RASA4DP | RASAL1 | RASAL2 | RASAL2-AS1 | RASAL3 | RASD1 | RASD2 | RASEF | RASGEF1A | RASGEF1B | RASGEF1C | RASGRF1 | RASGRF2 | RASGRP1 | RASGRP2 | RASGRP3 | RASGRP4 | RASIP1 | RASL10A | RASL10B | RASL11A | RASL11B | RASL12 | RASSF1 | RASSF10 | RASSF2 | RASSF3 | RASSF4 | RASSF5 | RASSF6